Oropharynx Cancer clinical trials at UC Irvine
1 research study open to eligible people
open to eligible people ages 18 years and up
This is a single-arm, observational registry study determining the effects of reduced radiation dose in select patients with human papillomavirus (HPV) positive oropharyngeal cancer.
Our lead scientists for Oropharynx Cancer research studies include Allen Chen.